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ORIGINAL ARTICLE
INTRODUCTION  
Gastroesophageal reflux is a normal physiological
phenomenon commonly experienced by most people,
particularly after meals.1 Gastroesophageal reflux
disease (GERD) is defined as a pathological
condition when the amount of gastric contents reflux
into the esophagus exceeds the normal limit, with
a variety of symptoms caused.1,2 It was known that
reflux into the esophagus can lead to symptoms to
extra-esophageal or esophagus itself, besides severe
complications such as stricture, Barrett’s esophagus
or even adenocarcinoma of the cardio and
esophagus.1,2 The prevalence of GERD in Asia,
including Indonesia, is relatively lower compared to
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Western countries. In America, nearly 7% of the
populations have a heartburn complaint, and 20-40%
of them are estimated to suffer from GERD.
Prevalence of esophagitis in the West ranged from
10-20%, while in Asia only 3-5%, with the exception
of Japan and Taiwan (13-15%).2,3 There is no gender
predilection on GERD, in which men and women have
the same risk, but the incidence of esophagitis in males
was higher (2:1-3:1), likewise the incidence of Barrett’s
esophagitis is also higher (10:1).1 GERD can also
occur in all age groups, but the prevalence increased
in age over 40 years.1
Pathogenesis of GERD involves a balance between
offensive factors namely reflux materials and
defensive factors. The defensive factors include the
anti-reflux dividing factor of lower esophageal
sphincter (LES), the clearance of acid from the lumen
of the esophagus, and the esophageal epithelial
resistance.2 Typical clinical symptoms of GERD are
heartburn (burning sensation in the chest
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accompanied by pain) and regurgitation (sour and
bitter taste on the tongue).3,4 Gold standard for
diagnosis of GERD according to the Montreal
Consensus in 2006 is 24-hour esophageal pH
monitoring.5 However Armstrong et al have reported
in Canadian digestive diseases week (CDDW) 20086
that health practitioners in the United States are still
difficult to perform esophageal pH monitoring for
GERD diagnosis, because of the constraints of facilities
and skills, and they generally prefer upper
gastrointestinal endoscopy. The National Consensus
2004 for gastro-esophageal reflux disease treatment
in Indonesia,3 has agreed on the basic standards of
diagnosis is the upper gastrointestinal endoscopy, which
is found of mucosal breaks in the esophagus as its
result. However, endoscopic examination of the upper
gastro-intestinal tract is not easy to be implemented as
the facilities and experts are not always available and
it is often less comfortable for patients. Besides, repeat
the procedure of the endoscopic examination for the
purpose of treatment’s evaluation is not practically to
do. Hence, there is a scoring system has been
developed for the screening and evaluation of GERD
therapy.7 Currently, a scoring system called the
frequency scale for the symptoms of GERD (FSSG)
has been developed in Japan to evaluate GERD
symptoms. This questionnaire specific to GERD, which
contains 12 questions consisted of seven questions
for reflux score and five questions to score the
dysmotility or dyspeptic.8 FSSG score has been
validated against the endoscopic findings in Japan
with the cut-off score (cut points) at 8, showed
sensitivity of 62%, specificity 59% and accuracy of
60%.9,10
Miyamoto et al found that high score FSSG is one
of the factors related to failure of proton pump
inhibitor (PPI) monotherapy, in addition to female,
alcohol consumption and obesity. Thus, GERD with a
high FSSG score requiring PPI combination therapy
with pro-kinetic drug for a more satisfactory outcome.8
The purpose of this study is to determine FSSG score
in patients with GERD at Koja hospital, in order to
predict the need for combination therapy of PPI with
pro-kinetic drug or PPI monotherapy only.
METHOD
This study used cross-sectional design, with the
population of all outpatients who visited Department
of Internal Medicine Koja hospital in the period of
March until July 2010. Samples were taken by using
non probability sampling that is consecutive sampling.
The inclusion criteria were the presence of
heartburn (burning sensation in the chest accompanied
by pain) and/or regurgitation (acid taste and bitter to
the tongue). Patients would be excluded if they
refused the interview or could not speak Indonesia.
Data was taken from all patients who met the
inclusion criteria and the FSSG score was obtain
containing the following questions:
1. Do you get heartburn? (reflux/acid-related
symptoms)
2. Does your stomach get bloated? (dyspeptic/
dysmotility symptoms)
3. Does your stomach ever feel heavy after meals?
(dyspeptic/dysmotility symptoms)
4. Do you sometimes subconsciously rub your chest
with your hand? (reflux/acid-related symptoms)
5. Do you ever feel sick after meals? (dyspeptic/
dysmotility symptoms)
6. Do you get heartburn after meals? (reflux/
acid-related symptoms)
7. Do you have an unusual (e.g. burning) sensation
in your throat? (reflux/acid-related symptoms)
8. Do you feel full while eating meals? (dyspeptic/
dysmotility symptoms)
9. Do some things get stuck when you swallow?
(reflux/acid-related symptoms)
10. Do you get bitter liquid (acid) coming up into your
throat? (reflux/acid-related symptoms)
11. Do you burp a lot? (dyspeptic/dysmotility
symptoms)
12. Do you get heartburn if you bend over? (reflux/
acid-related symptoms)
Seven questions (number 1, 4, 6, 7, 9 and 12) were
related to acid reflux, and 5 questions (number 2,3,5,8
and 11) were related to dyspeptic/dysmotility disorder.
For each question in FSSG scale, patients had given 5
choices answer: never (for score = 0), occasionally
(for score = 1), sometomes (for score = 2), often (for
score = 3), and always (for score = 4). Thus, the score
for reflux/acid-related symptoms was ranged between
0-28, the score for dyspeptic/dysmotility symptoms was
ranged between 0-20, and total score was ranged
between 0-48.
All the data was recorded in the entry form, and
further organized using descriptive statistics, presented
as mean ± SD for numerical data, and proportion (%)
for the categorical data.
RESULTS
Study has been done on patients with dyspepsia
who met the inclusion criteria, which are heartburn or
regurgitation, or both. There were 129 patients, 51
(39.5%) males. The mean age of 39.6 ± 15.5 years,
mostly in the age group of < 40 years (55.8%), followed
by the 40-60 years age group (38.8%) and only 5.4%
at age over 60 years. Body mass index (BMI) of most
patients (66.6%) were normal, overweight (BMI 25-
30 kg/m2) was found in 12.4% patients, 21% met the
criteria of underweight (BMI < 18.5 kg/m2), and there
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is no patients who meets the criteria of obese (BMI >
30 kg/m2).
A total of 47 (36.4%) patients complained of
heartburn, regurgitation was found in 70 (54.3%)
patients, whereas 12 (9.3%) patients had both
heartburn as well as regurgitation. FSSG score that
was conducted on 129 patients, revealed the mean of
total score of 17.6 ± 6.9 with the lowest score was 5
(found in 2 patients), and the highest score was 47
(found in one patient). When used the cut off 8 as
proposed by Kusano et al, then from 129 of dyspepsia
patients who complained heartburn and or regurgitation,
obtained 121 (93.8%) met criteria for GERD with cut
off 8 (figure 1). The rest is only 8 (6.2%) who do not
qualify for GERD FSSG score.
DISCUSSION
Most of the patients studied in present study were
female (60.5%). Some authors in Western countries
reported that gender differences did not influence the
incidence of GERD.1 However, this study found that
female patients with GERD are dominant compare to
male (60.5%, with a ratio of 1:1.5). Mantynen et al,
examined 3,378 patients with GERD, and got the ratio
of male: female was 1:1.3.11 In Japan, Miyamoto
studied 163 patients with GERD, 99 (60.7%) were
female. According to Miyamoto, female gender is a
factor associated with failure of PPI mono therapy.8
Thus, from the point of gender this study showed that
probability of failure of PPI mono therapy is
higher. Gender predominance of female in this study
was also more in line with Asian populations.6
BMI of most patients (66.6%) were normal,
overweight (BMI 25-30 kg/m2) was found in only 12.4
patients, 21% met the criteria of underweight
(BMI < 18.5 kg/m2), and there is no  patients who
meets the criteria of obese (BMI > 30 kg/m2). These
findings were not in accordance with the literature that
states obesity is a major risk factor
GERD.1,4,12 Malekzadeh et al reported some
significant risk factors for the occurrence of GERD,
such as obesity, high fat diet, too much eating, spicy
food, smoking, tight clothing, emotional stress, regular
fast food, tea and coffee, pregnancy, drugs, and habit
of laying down immediately after eating. Among all of
these factors, it is considered that obesity and high fat
diet play an important role in GERD.4 This lack of
conformity which may be obtained because the study
sample was small, or also because of confounding
factors in this study such as age, smoking, alcohol,
educational level, and the use of NSAIDs, were not
controlled.
The main clinical GERD complaint is heartburn and
regurgitation.3,4 In this study, 47 (36.4%) patients had
heartburn and 70 (54.3%) patients had a regurgitation
complaint, whereas 12 (9.3%) patients had both
heartburn as well as regurgitation. In the FSSG,
heartburn and regurgitation were classified into the
reflux score (corresponding to the questions number
1, 4 and 6). From 129 patients, this study has proved
more dominant regurgitation from heartburn complaints
(54.3% vs. 36.4%). In this study, if complaints related
to reflux compared with those related to dysmotility,
dysmotility symptoms was proved to be more
dominant than acid reflux (7.4 ± 4.6 vs. 10.1 ± 4).
When used FSSG score as a screening, by using
the cut off number of 8,9,10 it turns out from 129
patients were diagnosed based on a complaint heartburn
and regurgitation, as many as 94% did meet a score of
GERD according to the FSSG. The mean FSSG score
in this study was quite high, that was
From the total score of 17.6 ± 6.9, a mean reflux
score is 7.4 ± 4.6 with range of lowest value 0 and the
highest 21 was obtained. The mean of dyspeptic/
dysmotility score was 10.1 ± 4 with a range second
lowest and the highest 20. Mean score of reflux (7.4)
represents 26.5% of the total score of reflux (total
score 28), while the mean of dyspeptic/dysmotility score
was (10.1 ± 4) is 50.6% of the total score of dyspeptic/
dysmotility (total score 20). Thus from 129 patients
studied, the symptoms of dyspeptic/dysmotility more
dominant than symptoms of reflux.
 
Figure 1. Proportion of GERD according FSSG score in 129
patients
Table 1. Patients characteristic 
Characteristic Mean ± SD n (%) 
Sex   
 Male 
Female 
 51 (39.5) 
78 (60.5) 
Age (years old) 39.6 ± 15.5  
 < 40 
40-60 
> 60 
 72 (55.8) 
50 (38.8) 
7 (5.4) 
Body mass index (kg/m2)   
 Underweight (< 18.5)  
Normal weight (18.5-24.9) 
Overweight (25-30) 
 27 (21) 
86 (66.6) 
16 (12.4) 
Chief complaint   
 Heartburn 
Regurgitation 
Heartburn + regurgitation 
 47 (36.4) 
70 (54.3) 
12 (9.3) 
FSSG score 17.6 ± 6.9  
 Reflux score 
Dyspeptic score 
7.4 ± 4.6 
10.1 ± 4 
 
SD: standard deviation   
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17.6 ± 6.9. According to the study of Miyamoto et al,
this high score became a factor associated with failure
of PPI monotherapy.  In his study, Miyamoto et al
found that a group that failed with PPI monotherapy
had a mean FSSG score of 17.4, and then that group
was given a combination therapy of PPI with
prokinetic.8 Miyamoto proposed that pretreatment
FSSG scores can be used to predict the need for the
addition of a prokinetic agent to PPI therapy prior to
treatment.8 Japanese physicians usually add prokinetic
agent to the standard dose of a PPIs instead of
doubling the dose of the PPI for cases refractory to
PPI monotherapy. 
PPIs are unstable at a low pH dysmotility will slow
down gastric emptying, resulting in retention of PPIs.
Retention of PPIs inside the stomach for a long time
may result in an impaired acid suppressive effect, so
rapid transit of the PPIs to the upper intestine will be
of benefit. Based on this, then combination of PPIs
with prokinetic will improve the effect of PPIs.8
CONCLUSION
GERD patients in Koja hospital have a high mean
FSSG score, whereas dysmotility symptoms were
proved to be more dominant than acid reflux.
SUGGESTION
Based on the findings in this study, combination
therapy is recommended. In this group, the use of
prokinetic combination therapy with PPI is considered
more effective than PPI therapy alone. Further study
is needed to assess the FSSG score improvement in
patients receiving combination therapy PPIs with
prokinetic compared to PPIs monotherapy alone.
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